Kevin Buehler - 20 May 2026 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Reporting relationship: Director
Issuer ticker: DTIL
Reported as of: 20 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 May 2026, 07:31:47 UTC
Prior SEC filing: 27 Jun 2025
Next SEC filing: 05 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Dario Scimeca, Attorney-in-Fact for Kevin Buehler

Key filing fact

Kevin Buehler filed Form 4 for PRECISION BIOSCIENCES INC (DTIL) on 22 May 2026.

Key facts

This page summarizes Kevin Buehler's Form 4 filing for PRECISION BIOSCIENCES INC (DTIL).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 22 May 2026, 07:31.

Change

Previous filing in this sequence was filed on 27 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001792722 Primary reporting owner

Buehler Kevin

Relationship: Director
Address: C/O PRECISION BIOSCIENCES, INC., 302 E. PETTIGREW ST, SUITE A-100, DURHAM
Signature: /s/ Dario Scimeca, Attorney-in-Fact for Kevin Buehler
Signature date: 22 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DTIL transaction

Common Stock

Options Exercise

Transaction value
Shares: +21,000
Change %: +75%
Price
Shares after: 49,137
Date: 20 May 2026
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DTIL transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -21,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 20 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 21,000
Exercise price
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents the vesting of Restricted Stock Units ("RSUs") on May 20, 2026.

Footnote F2

Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Footnote F3

On June 3, 2025 the Reporting person was granted RSUs. The RSUs vested on the earlier to occur of (i) June 3, 2026 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.